Gene News and Research

Latest Gene News and Research

Baxter to develop recombinant Factor IX proteins to treat hemophilia B

Baxter International Inc. has announced that it has initiated pre-clinical programs to develop recombinant Factor IX proteins to treat hemophilia B.

From Baxter International Inc. 7 Jan 2008

Chlamydia trachomatis genome sheds light on an emerging infection

Researchers have decoded the genome of the strain of Chlamydia that causes the most severe, invasive form of the disease. Their study shows that, despite recent increases in invasive infections, the strain has remained virtually unchanged for 40 years.

7 Jan 2008

New biomarker for predicting liver cancer spread and survival discovered

New research has shown that a unique pattern of microRNAs, small RNA molecules that regulate gene activity, can accurately predict whether liver cancer will spread and whether liver cancer patients will have shorter or longer survival, even patients with early stage disease.

7 Jan 2008

New understanding of cell's inner workings

A group of scientists in Princeton's Department of Ecology and Evolutionary Biology has uncovered a new biological mechanism that could provide a clearer window into a cell's inner workings.

7 Jan 2008

Researchers overcome oxygen deficiency

No life without oxygen - but oxygen can also be harmful Oxygen is necessary to life.

7 Jan 2008

Comprehensive gene atlas underlying drug addiction

Using an integrative meta-analysis approach, researchers from the Center for Bioinformatics at Peking University in Beijing have assembled the most comprehensive gene atlas underlying drug addiction and identified five molecular pathways common to four different addictive drugs.

7 Jan 2008

The dopamine transporter gene influences alcohol withdrawal seizures

The physiological component of alcoholism is defined by tolerance and/or withdrawal: the more severe the dependency on alcohol, the more severe the clinical complications, such as greater intensity and/or complications of alcohol withdrawal.

4 Jan 2008

Gene therapy can reduce long-term drinking among rodents

Just as the risk of developing alcoholism is strongly influenced by genetic factors, mutations in gene coding - such as the aldehyde dehydrogenase (ALDH2*2) allele - also appear to protect against the risk.

4 Jan 2008

Down syndrome points to a new way of repressing cancer growth

Researchers at Johns Hopkins and Ohio State University have found that the number of copies of a particular gene can affect the severity of colon cancer in a mouse model. Publishing in the Jan. 3 issue of Nature, the research team describes how trisomy 21, or Down syndrome in humans, can repress tumor growth.

4 Jan 2008

Down's syndrome gene protects against cancer

Researchers in the United States say the chromosomal abnormality that affects people with Down's syndrome also protects them against cancer.

3 Jan 2008

Deadly vCJD makes a comeback in Britain

A new report has reignited fears over another possible outbreak of the deadly Creutzfeldt-Jakob Disease (CJD) in Britain.

3 Jan 2008

Scientists find missing evolutionary link using tiny fungus crystal

The crystal structure of a molecule from a primitive fungus has served as a time machine to show researchers more about the evolution of life from the simple to the complex.

3 Jan 2008

Researchers seek to make cavity-causing bacteria self-destruct

Bacteria that eat sugar and release cavity-causing acid onto teeth may soon be made dramatically more vulnerable to their own acid.

3 Jan 2008

Il-22 gene delivers the goods and decreases intestinal inflammation

There are two major types of inflammatory bowel disease (IBD), Crohn disease (CD) and ulcerative colitis (UC).

3 Jan 2008

Boost for Fragile X research

The 2008 Omnibus Budget, signed by President George Bush on Monday, includes $1,860,000 for the CDC Fragile X Public Health Initiative, more than double the current program funding level.

3 Jan 2008

BD Diagnostics announces FDA clearance of test to identify superbug

BD Diagnostics, a segment of BD (Becton, Dickinson and Company), has announced that it received clearance from the U.S. Food and Drug Administration (FDA) for the BD GeneOhm StaphSR assay.

From BD (Becton, Dickinson and Company) 3 Jan 2008

Artificial viral shells for pinpoint drug delivery

Researchers at the Technion-Israel Institute of Technology and The Scripps Research Institute in California are designing an artificial viral shell as a valuable nano-container for pinpoint drug delivery, molecular computing components, and a host of other applications.

3 Jan 2008